Evidence map›Paper›PMID 32038247›Full record

ArticleFrontiers in pharmacology2019

Chinese Herbal Medicine (MaZiRenWan) Improves Bowel Movement in Functional Constipation Through Down-Regulating Oleamide.

Tao Huang, Ling Zhao, Cheng-Yuan Lin, Lin Lu, Zi-Wan Ning, Dong-Dong Hu, Linda L D Zhong, Zhi-Jun Yang, Zhao-Xiang Bian

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 2 countries.

Tao HuangInstitute of Brain and Gut Research, School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, Hong Kong.
Ling ZhaoInstitute of Brain and Gut Research, School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, Hong Kong.
Cheng-Yuan LinInstitute of Brain and Gut Research, School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, Hong Kong.
Lin LuInstitute of Brain and Gut Research, School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, Hong Kong.
Zi-Wan NingInstitute of Brain and Gut Research, School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, Hong Kong.
Dong-Dong HuInstitute of Brain and Gut Research, School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, Hong Kong.
Linda L D ZhongInstitute of Brain and Gut Research, School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, Hong Kong.
Zhi-Jun YangInstitute of Brain and Gut Research, School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, Hong Kong.
Zhao-Xiang BianInstitute of Brain and Gut Research, School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, Hong Kong.
Hong Kong Baptist University · HK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In a prospective, randomized, three-arms, controlled clinical study, Chinese Herbal Medicine MaZiRenWan (MZRW, also known as Hemp Seed Pill) demonstrates comparable efficacy with Senna for functional constipation (FC) during an 8-week treatment period. Both MZRW and Senna are better than a placebo; relative to Senna and a placebo, MZRW displayed a more sustained effect during the 8-week follow-up period. The characteristic pharmacological mechanism responsible for this observation is still unclear. To explore this, we collected pre- and post-treatment serum samples of 85 FC patients from MZRW/Senna/placebo treatment groups for pharmacometabolomic analysis. An ultrahigh-performance liquid chromatography-mass spectrometer (UPLC-MS) was used for metabolic profiling and quantification.

Indexed as

fatty acid amide hydrolasefunctional constipationMaZiRenWanoleamidepharmacometabolomics

Identifiers

PMID32038247
PMCPMC6989537
OpenAlexW3001704332

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.